Free Trial
NASDAQ:AAPG

Ascentage Pharma Group International (AAPG) Stock Price, News & Analysis

Ascentage Pharma Group International logo
$18.70 -0.30 (-1.58%)
As of 04:00 PM Eastern

About Ascentage Pharma Group International Stock (NASDAQ:AAPG)

Key Stats

Today's Range
$18.47
$19.06
50-Day Range
N/A
52-Week Range
$16.50
$21.40
Volume
8,496 shs
Average Volume
109,040 shs
Market Capitalization
$1.63 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Remove Ads
Receive AAPG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter.

AAPG Stock News Headlines

Silent Raid on IRAs and 401(k)s Begins—Are You Next?
Look around—everything feels oddly steady. Gas prices aren't skyrocketing. Banks aren't collapsing. The markets? They're holding up—for now. But if history has taught us anything, it's this: when things feel too quiet, chaos is right around the corner.
See More Headlines

AAPG Stock Analysis - Frequently Asked Questions

Ascentage Pharma Group International's stock was trading at $18.67 on January 1st, 2025. Since then, AAPG shares have increased by 0.2% and is now trading at $18.70.
View the best growth stocks for 2025 here
.

Ascentage Pharma Group International (AAPG) raised $126 million in an initial public offering on Friday, January 24th 2025. The company issued 7,325,000 shares at a price of $17.25 per share.

Ascentage Pharma Group International's quiet period expired on Wednesday, March 5th. Ascentage Pharma Group International had issued 7,325,000 shares in its public offering on January 24th. The total size of the offering was $126,356,250 based on an initial share price of $17.25. During the company's quiet period, underwriters and any insiders that worked on the IPO were prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Shares of AAPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
3/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AAPG
Previous Symbol
NASDAQ:AAPG
Web
N/A
Fax
N/A
Employees
600
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$903.03 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.63 billion
Optionable
N/A
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:AAPG) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners